{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:36:39Z","timestamp":1794573399355,"version":"4.9.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DP1OD025535"],"award-info":[{"award-number":["DP1OD025535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UF1MH128336"],"award-info":[{"award-number":["UF1MH128336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD011107"],"award-info":[{"award-number":["P51OD011107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UF1MH128336"],"award-info":[{"award-number":["UF1MH128336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health &Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM118191"],"award-info":[{"award-number":["R35GM118191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merkin Institute (Reference: Translational Research Grant) Caltech Beckman Institute"},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P500PN_210720"],"award-info":[{"award-number":["P500PN_210720"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["VR-2022-06175"],"award-info":[{"award-number":["VR-2022-06175"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The blood\u2212brain barrier (BBB) presents a challenge for central nervous system (CNS) therapies. Receptor-mediated transcytosis offers a solution, but existing receptor targets are ubiquitous across CNS and peripheral tissues, causing unintended exposure. We identified carbonic anhydrase IV (CA-IV) as a brain-enriched receptor enabling engineered viral capsids to cross the BBB. However, it is unclear whether CA-IV can also mediate non-viral delivery. We thus designed a reactive small-molecule shuttle, derived from an FDA-approved binder, that couples to proteins and oligonucleotides in a single step. We validated the binding of conjugated molecules to multiple mammalian CA-IV orthologs and subsequent internalization in cell-based assays. After systemic dosing, CA-IV-targeted antibody conjugates crossed the BBB in mice and neonatal macaques, preferentially accumulating in the brain and sustaining parenchymal levels for at least 7\u2009days. This BrainCAB (Brain access through Carbonic Anhydrase-binder Bioconjugation) technology offers a compact, modular shuttle for selective and prolonged CNS delivery of large molecules.<\/jats:p>","DOI":"10.1038\/s41589-026-02294-y","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:03:15Z","timestamp":1787734995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CA-IV-directed small-molecule shuttle enables targeted brain delivery of biologics"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0267-0791","authenticated-orcid":false,"given":"Xiaozhe","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0408-0813","authenticated-orcid":false,"given":"Xinhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Carretero-Cerd\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-6790","authenticated-orcid":false,"given":"Seongmin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-6520","authenticated-orcid":false,"given":"Erin E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Arokiaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Ristic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill C.","family":"Kavvathas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian J.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-7618","authenticated-orcid":false,"given":"Shawn","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Shahgholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-3549","authenticated-orcid":false,"given":"Danielle","family":"Mantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-3271","authenticated-orcid":false,"given":"Timothy F.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5868-348X","authenticated-orcid":false,"given":"Viviana","family":"Gradinaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2294_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R. & Begley, D. J. Structure and function of the blood\u2212brain barrier. Neurobiol. Dis. 37, 13\u201325 (2010).","journal-title":"Neurobiol. Dis."},{"key":"2294_CR2","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman, R. & Prat, A. The blood\u2013brain barrier. Cold Spring Harb. Perspect. Biol. 7, a020412 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2294_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R. & Zlokovic, B. V. Blood-brain barrier: from physiology to disease and back. Physiol. Rev. 99, 21\u201378 (2019).","journal-title":"Physiol. Rev."},{"key":"2294_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn2995","volume":"12","author":"EA Neuwelt","year":"2011","unstructured":"Neuwelt, E. A. et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat. Rev. Neurosci. 12, 169\u2013182 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"2294_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. Strategies for delivering therapeutics across the blood\u2013brain barrier. Nat. Rev. Drug Discov. 20, 362\u2013383 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2294_CR6","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1021\/cr078203u","volume":"108","author":"EL Que","year":"2008","unstructured":"Que, E. L., Domaille, D. W. & Chang, C. J. Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem. Rev. 108, 1517\u20131549 (2008).","journal-title":"Chem. Rev."},{"key":"2294_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge, W. M. The blood\u2212brain barrier: bottleneck in brain drug development. NeuroRx 2, 3\u201314 (2005).","journal-title":"NeuroRx"},{"key":"2294_CR8","unstructured":"Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches (eds de Lange, E. C. M., Hammarlund-Udenaes, M. & Thorne, R. G.) (Springer, 2022)."},{"key":"2294_CR9","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1073\/pnas.91.12.5705","volume":"91","author":"JF Poduslo","year":"1994","unstructured":"Poduslo, J. F., Curran, G. L. & Berg, C. T. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc. Natl Acad. Sci. USA 91, 5705\u20135709 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2294_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","volume":"33","author":"I St-Amour","year":"2013","unstructured":"St-Amour, I. et al. Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood\u2212brain barrier. J. Cereb. Blood Flow Metab. 33, 1983\u20131992 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2294_CR11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/mp400680d","volume":"11","author":"A Lalatsa","year":"2014","unstructured":"Lalatsa, A., Schatzlein, A. G. & Uchegbu, I. F. Strategies to deliver peptide drugs to the brain. Mol. Pharm. 11, 1081\u20131093 (2014).","journal-title":"Mol. Pharm."},{"key":"2294_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","volume":"36","author":"M Zheng","year":"2018","unstructured":"Zheng, M., Tao, W., Zou, Y., Farokhzad, O. C. & Shi, B. Nanotechnology-based strategies for siRNA brain delivery for disease therapy. Trends Biotechnol. 36, 562\u2013575 (2018).","journal-title":"Trends Biotechnol."},{"key":"2294_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","volume":"30","author":"VW Pike","year":"2009","unstructured":"Pike, V. W. PET radiotracers: crossing the blood\u2212brain barrier and surviving metabolism. Trends Pharmacol. Sci. 30, 431\u2013440 (2009).","journal-title":"Trends Pharmacol. Sci."},{"key":"2294_CR14","doi-asserted-by":"publisher","first-page":"16280","DOI":"10.1073\/pnas.1409796111","volume":"111","author":"SC Dodani","year":"2014","unstructured":"Dodani, S. C. et al. Copper is an endogenous modulator of neural circuit spontaneous activity. Proc. Natl Acad. Sci. USA 111, 16280\u201316285 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2294_CR15","doi-asserted-by":"publisher","first-page":"23668","DOI":"10.1021\/jacs.2c11223","volume":"144","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Photostable small-molecule NIR-II fluorescent scaffolds that cross the blood-brain barrier for noninvasive brain imaging. J. Am. Chem. Soc. 144, 23668\u201323676 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"2294_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molmed.2023.12.006","volume":"30","author":"RH Kofoed","year":"2024","unstructured":"Kofoed, R. H. & Aubert, I. Focused ultrasound gene delivery for the treatment of neurological disorders. Trends Mol. Med. 30, 263\u2013277 (2024).","journal-title":"Trends Mol. Med."},{"key":"2294_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00259-022-05997-1","volume":"50","author":"WJ Harris","year":"2023","unstructured":"Harris, W. J. et al. In vivo methods for imaging blood\u2013brain barrier function and dysfunction. Eur. J. Nucl. Med. Mol. Imaging 50, 1051\u20131083 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2294_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16924-z","volume":"11","author":"B Li","year":"2020","unstructured":"Li, B. et al. Organic NIR-II molecule with long blood half-life for in vivo dynamic vascular imaging. Nat. Commun. 11, 3102 (2020).","journal-title":"Nat. Commun."},{"key":"2294_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nphoton.2014.166","volume":"8","author":"G Hong","year":"2014","unstructured":"Hong, G. et al. Through-skull fluorescence imaging of the brain in a new near-infrared window. Nat. Photonics 8, 723\u2013730 (2014).","journal-title":"Nat. Photonics"},{"key":"2294_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nmat4476","volume":"15","author":"AL Antaris","year":"2016","unstructured":"Antaris, A. L. et al. A small-molecule dye for NIR-II imaging. Nat. Mater. 15, 235\u2013242 (2016).","journal-title":"Nat. Mater."},{"key":"2294_CR21","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.adm8386","volume":"384","author":"Q Huang","year":"2024","unstructured":"Huang, Q. et al. An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery. Science 384, 1220\u20131227 (2024).","journal-title":"Science"},{"key":"2294_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1359","volume":"12","author":"MS Kariolis","year":"2020","unstructured":"Kariolis, M. S. et al. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci. Transl. Med. 12, eaay1359 (2020).","journal-title":"Sci. Transl. Med."},{"key":"2294_CR23","doi-asserted-by":"publisher","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","volume":"3","author":"YJ Yu","year":"2011","unstructured":"Yu, Y. J. et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci. Transl. Med. 3, 84ra44 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2294_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40681-4","volume":"14","author":"KS Chew","year":"2023","unstructured":"Chew, K. S. et al. CD98hc is a target for brain delivery of biotherapeutics. Nat. Commun. 14, 5053 (2023).","journal-title":"Nat. Commun."},{"key":"2294_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2261509","volume":"15","author":"HP Grimm","year":"2023","unstructured":"Grimm, H. P. et al. Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans. mAbs 15, 2261509 (2023).","journal-title":"mAbs"},{"key":"2294_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","volume":"89","author":"YJY Zuchero","year":"2016","unstructured":"Zuchero, Y. J. Y. et al. Discovery of novel blood-brain barrier targets to enhance brain uptake of therapeutic antibodies. Neuron 89, 70\u201382 (2016).","journal-title":"Neuron"},{"key":"2294_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57108-x","volume":"16","author":"N Khoury","year":"2025","unstructured":"Khoury, N. et al. Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution. Nat. Commun. 16, 1822 (2025).","journal-title":"Nat. Commun."},{"key":"2294_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","volume":"81","author":"J Niewoehner","year":"2014","unstructured":"Niewoehner, J. et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 81, 49\u201360 (2014).","journal-title":"Neuron"},{"key":"2294_CR29","doi-asserted-by":"publisher","first-page":"e1695","DOI":"10.1002\/wnan.1695","volume":"13","author":"X Zhou","year":"2021","unstructured":"Zhou, X., Smith, Q. R. & Liu, X. Brain penetrating peptides and peptide\u2013drug conjugates to overcome the blood\u2013brain barrier and target CNS diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 13, e1695 (2021).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"2294_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.medj.2022.09.007","volume":"3","author":"S Edavettal","year":"2022","unstructured":"Edavettal, S. et al. Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis. Med 3, 860\u2013882.e15 (2022).","journal-title":"Med"},{"key":"2294_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.chembiol.2023.09.008","volume":"31","author":"G Pornnoppadol","year":"2024","unstructured":"Pornnoppadol, G. et al. Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs. Cell Chem. Biol. 31, 361\u2013372.e8 (2024).","journal-title":"Cell Chem. Biol."},{"key":"2294_CR32","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","volume":"58","author":"Z Rankovic","year":"2015","unstructured":"Rankovic, Z. CNS drug design: balancing physicochemical properties for optimal brain exposure. J. Med. Chem. 58, 2584\u20132608 (2015).","journal-title":"J. Med. Chem."},{"key":"2294_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","volume":"2","author":"H Pajouhesh","year":"2005","unstructured":"Pajouhesh, H. & Lenz, G. R. Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2, 541\u2013553 (2005).","journal-title":"NeuroRx"},{"key":"2294_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","volume":"29","author":"T Okuyama","year":"2021","unstructured":"Okuyama, T. et al. A phase 2\/3 trial of pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II. Mol. Ther. 29, 671\u2013679 (2021).","journal-title":"Mol. Ther."},{"key":"2294_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/312162a0","volume":"312","author":"WA Jefferies","year":"1984","unstructured":"Jefferies, W. A. et al. Transferrin receptor on endothelium of brain capillaries. Nature 312, 162\u2013163 (1984).","journal-title":"Nature"},{"key":"2294_CR36","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/j.1471-4159.1985.tb07167.x","volume":"44","author":"WM Pardridge","year":"1985","unstructured":"Pardridge, W. M., Eisenberg, J. & Yang, J. Human blood\u2212brain barrier insulin receptor. J. Neurochem. 44, 1771\u20131778 (1985).","journal-title":"J. Neurochem."},{"key":"2294_CR37","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"2294_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-020-00209-0","volume":"17","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human. Fluids Barriers CNS 17, 47 (2020).","journal-title":"Fluids Barriers CNS"},{"key":"2294_CR39","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/pmic.201400441","volume":"15","author":"M Wang","year":"2015","unstructured":"Wang, M., Herrmann, C. J., Simonovic, M., Szklarczyk, D. & von Mering, C. Version 4.0 of PaxDb: protein abundance data, integrated across model organisms, tissues, and cell-lines. Proteomics 15, 3163\u20133168 (2015).","journal-title":"Proteomics"},{"key":"2294_CR40","doi-asserted-by":"publisher","first-page":"183ra57","DOI":"10.1126\/scitranslmed.3005338","volume":"5","author":"JA Couch","year":"2013","unstructured":"Couch, J. A. et al. Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier. Sci. Transl. Med. 5, 183ra57 (2013).","journal-title":"Sci. Transl. Med."},{"key":"2294_CR41","doi-asserted-by":"publisher","first-page":"10706","DOI":"10.1073\/pnas.162362999","volume":"99","author":"PP Ng","year":"2002","unstructured":"Ng, P. P. et al. An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc. Natl Acad. Sci. USA 99, 10706\u201310711 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2294_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.celrep.2017.12.019","volume":"22","author":"F Weber","year":"2018","unstructured":"Weber, F. et al. Brain shuttle antibody for Alzheimer\u2019s disease with attenuated peripheral effector function due to an inverted binding mode. Cell Rep. 22, 149\u2013162 (2018).","journal-title":"Cell Rep."},{"key":"2294_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-024-07493-y","volume":"632","author":"T W\u00e4lchli","year":"2024","unstructured":"W\u00e4lchli, T. et al. Single-cell atlas of the human brain vasculature across development, adulthood and disease. Nature 632, 603\u2013613 (2024).","journal-title":"Nature"},{"key":"2294_CR44","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41593-024-01636-0","volume":"27","author":"KJM Benjamin","year":"2024","unstructured":"Benjamin, K. J. M. et al. Analysis of gene expression in the postmortem brain of neurotypical Black Americans reveals contributions of genetic ancestry. Nat. Neurosci. 27, 1064\u20131074 (2024).","journal-title":"Nat. Neurosci."},{"key":"2294_CR45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","volume":"603","author":"AC Yang","year":"2022","unstructured":"Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature 603, 885\u2013892 (2022).","journal-title":"Nature"},{"key":"2294_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2453-z","volume":"583","author":"AC Yang","year":"2020","unstructured":"Yang, A. C. et al. Physiological blood\u2013brain transport is impaired with age by a shift in transcytosis. Nature 583, 425\u2013430 (2020).","journal-title":"Nature"},{"key":"2294_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0271678X251361997","volume":"46","author":"VO Torres","year":"2026","unstructured":"Torres, V. O. et al. Transferrin receptor-mediated transport at the blood\u2212brain barrier is elevated during early development and maintained across aging and in an Alzheimer\u2019s mouse model. J. Cereb. Blood Flow Metab. 46, 20\u201335 (2026).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2294_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6618","volume":"9","author":"TF Shay","year":"2023","unstructured":"Shay, T. F. et al. Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors. Sci. Adv. 9, eadg6618 (2023).","journal-title":"Sci. Adv."},{"key":"2294_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52149-0","volume":"15","author":"TF Shay","year":"2024","unstructured":"Shay, T. F. et al. Human cell surface-AAV interactomes identify LRP6 as blood\u2212brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder. Nat. Commun. 15, 7853 (2024).","journal-title":"Nat. Commun."},{"key":"2294_CR50","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.ymthe.2025.04.046","volume":"33","author":"TC Moyer","year":"2025","unstructured":"Moyer, T. C. et al. Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier. Mol. Ther. 33, 3902\u20133916 (2025).","journal-title":"Mol. Ther."},{"key":"2294_CR51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman, B. E. et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204\u2013209 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2294_CR52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41592-020-0799-7","volume":"17","author":"S Ravindra Kumar","year":"2020","unstructured":"Ravindra Kumar, S. et al. Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types. Nat. Methods 17, 541\u2013550 (2020).","journal-title":"Nat. Methods"},{"key":"2294_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-neuro-111020-100834","volume":"45","author":"RC Challis","year":"2022","unstructured":"Challis, R. C. et al. Adeno-associated virus toolkit to target diverse brain cells. Annu. Rev. Neurosci. 45, 447\u2013469 (2022).","journal-title":"Annu. Rev. Neurosci."},{"key":"2294_CR54","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","volume":"20","author":"M Nonnenmacher","year":"2021","unstructured":"Nonnenmacher, M. et al. Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning. Mol. Ther. Methods Clin. Dev. 20, 366\u2013378 (2021).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2294_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtm.2019.10.007","volume":"15","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. Selection of an efficient AAV vector for robust CNS transgene expression. Mol. Ther. Methods Clin. Dev. 15, 320\u2013332 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2294_CR56","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"2294_CR57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41583-020-00382-z","volume":"21","author":"AR Nectow","year":"2020","unstructured":"Nectow, A. R. & Nestler, E. J. Viral tools for neuroscience. Nat. Rev. Neurosci. 21, 669\u2013681 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"2294_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-020-15818-4","volume":"11","author":"JW Seo","year":"2020","unstructured":"Seo, J. W. et al. Positron emission tomography imaging of novel AAV capsids maps rapid brain accumulation. Nat. Commun. 11, 102 (2020).","journal-title":"Nat. Commun."},{"key":"2294_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225206","volume":"14","author":"Q Huang","year":"2019","unstructured":"Huang, Q. et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS ONE 14, e0225206 (2019).","journal-title":"PLoS ONE"},{"key":"2294_CR60","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ymthe.2019.02.013","volume":"27","author":"J Hordeaux","year":"2019","unstructured":"Hordeaux, J. et al. The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood-brain barrier. Mol. Ther. 27, 912\u2013921 (2019).","journal-title":"Mol. Ther."},{"key":"2294_CR61","doi-asserted-by":"crossref","unstructured":"Waheed, A. & Sly, W. S. Membrane associated carbonic anhydrase IV (CA IV): a personal and historical perspective. In Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications (eds Frost, S. C. & McKenna, R.) 157\u2013179 (Springer, 2014).","DOI":"10.1007\/978-94-007-7359-2_9"},{"key":"2294_CR62","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1073\/pnas.89.15.6823","volume":"89","author":"MS Ghandour","year":"1992","unstructured":"Ghandour, M. S., Langley, O. K., Zhu, X. L., Waheed, A. & Sly, W. S. Carbonic anhydrase IV on brain capillary endothelial cells: a marker associated with the blood-brain barrier. Proc. Natl Acad. Sci. USA 89, 6823\u20136827 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2294_CR63","doi-asserted-by":"publisher","first-page":"L627","DOI":"10.1152\/ajplung.1993.265.6.L627","volume":"265","author":"RE Fleming","year":"1993","unstructured":"Fleming, R. E., Crouch, E. C., Ruzicka, C. A. & Sly, W. S. Pulmonary carbonic anhydrase IV: developmental regulation and cell-specific expression in the capillary endothelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 265, L627\u2013L635 (1993).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2294_CR64","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/42.9.8064130","volume":"42","author":"S Sender","year":"1994","unstructured":"Sender, S., Gros, G., Waheed, A., Hageman, G. S. & Sly, W. S. Immunohistochemical localization of carbonic anhydrase IV in capillaries of rat and human skeletal muscle. J. Histochem. Cytochem. 42, 1229\u20131236 (1994).","journal-title":"J. Histochem. Cytochem."},{"key":"2294_CR65","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1172\/JCI118362","volume":"96","author":"RE Fleming","year":"1995","unstructured":"Fleming, R. E. et al. Carbonic anhydrase IV expression in rat and human gastrointestinal tract regional, cellular, and subcellular localization. J. Clin. Invest. 96, 2907\u20132913 (1995).","journal-title":"J. Clin. Invest."},{"key":"2294_CR66","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ccell.2023.12.018","volume":"42","author":"L Bejarano","year":"2024","unstructured":"Bejarano, L. et al. Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms. Cancer Cell 42, 378\u2013395 (2024).","journal-title":"Cancer Cell"},{"key":"2294_CR67","doi-asserted-by":"crossref","unstructured":"Parkkila, S. An overview of the distribution and function of carbonic anhydrase in mammals. In The Carbonic Anhydrases: New Horizons (eds Chegwidden, W. R., Carter, N. D. & Edwards, Y. H.) 79\u201393 (Birkh\u00e4user, 2000).","DOI":"10.1007\/978-3-0348-8446-4_4"},{"key":"2294_CR68","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"CT Supuran","year":"2003","unstructured":"Supuran, C. T., Scozzafava, A. & Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 23, 146\u2013189 (2003).","journal-title":"Med. Res. Rev."},{"key":"2294_CR69","doi-asserted-by":"publisher","first-page":"e1011953","DOI":"10.1371\/journal.ppat.1011953","volume":"20","author":"R Zhang","year":"2024","unstructured":"Zhang, R. et al. Structural basis of the recognition of adeno-associated virus by the neurological system-related receptor carbonic anhydrase IV. PLoS Pathog. 20, e1011953 (2024).","journal-title":"PLoS Pathog."},{"key":"2294_CR70","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1021\/acs.chemrev.8b00201","volume":"119","author":"AY Chen","year":"2019","unstructured":"Chen, A. Y. et al. Targeting metalloenzymes for therapeutic intervention. Chem. Rev. 119, 1323\u20131455 (2019).","journal-title":"Chem. Rev."},{"key":"2294_CR71","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/pro.5560070303","volume":"7","author":"T Stams","year":"1998","unstructured":"Stams, T. et al. Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination. Protein Sci. 7, 556\u2013563 (1998).","journal-title":"Protein Sci."},{"key":"2294_CR72","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/S0039-6257(99)00108-3","volume":"44","author":"L DeSantis","year":"2000","unstructured":"DeSantis, L. Preclinical overview of brinzolamide. Surv. Ophthalmol. 44, S119\u2013S129 (2000).","journal-title":"Surv. Ophthalmol."},{"key":"2294_CR73","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1016\/j.bmc.2013.08.033","volume":"21","author":"MA Pinard","year":"2013","unstructured":"Pinard, M. A., Boone, C. D., Rife, B. D., Supuran, C. T. & McKenna, R. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases. Bioorg. Med. Chem. 21, 7210\u20137215 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"2294_CR74","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1021\/acs.jmedchem.7b00237","volume":"60","author":"P Matsson","year":"2017","unstructured":"Matsson, P. & Kihlberg, J. How big is too big for cell permeability? J. Med. Chem. 60, 1662\u20131664 (2017).","journal-title":"J. Med. Chem."},{"key":"2294_CR75","unstructured":"Package insert of AZOPT (brinzolamide ophthalmic suspension) (Novartis, 2015)."},{"key":"2294_CR76","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1874121","volume":"13","author":"H-Y Chang","year":"2021","unstructured":"Chang, H.-Y. et al. Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis. mAbs 13, 1874121 (2021).","journal-title":"mAbs"},{"key":"2294_CR77","doi-asserted-by":"publisher","first-page":"261ra154","DOI":"10.1126\/scitranslmed.3009835","volume":"6","author":"YJ Yu","year":"2014","unstructured":"Yu, Y. J. et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. Sci. Transl. Med. 6, 261ra154 (2014).","journal-title":"Sci. Transl. Med."},{"key":"2294_CR78","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1021\/acs.molpharmaceut.7b00937","volume":"15","author":"G Thom","year":"2018","unstructured":"Thom, G. et al. Enhanced delivery of galanin conjugates to the brain through bioengineering of the anti-transferrin receptor antibody OX26. Mol. Pharm. 15, 1420\u20131431 (2018).","journal-title":"Mol. Pharm."},{"key":"2294_CR79","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/OPTH.S3182","volume":"2","author":"M Iester","year":"2008","unstructured":"Iester, M. Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension. Clin. Ophthalmol. 2, 517\u2013523 (2008).","journal-title":"Clin. Ophthalmol."},{"key":"2294_CR80","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2165\/00002512-200320120-00008","volume":"20","author":"RS Cvetkovic","year":"2003","unstructured":"Cvetkovic, R. S. & Perry, C. M. Brinzolamide: a review of its use in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging 20, 919\u2013947 (2003).","journal-title":"Drugs Aging"},{"key":"2294_CR81","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/j.1471-4159.1990.tb04886.x","volume":"54","author":"D Triguero","year":"1990","unstructured":"Triguero, D., Buciak, J. & Pardridge, W. M. Capillary depletion method for quantification of blood\u2013brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54, 1882\u20131888 (1990).","journal-title":"J. Neurochem."},{"key":"2294_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1365-2990.1986.tb00146.x","volume":"12","author":"K M\u00f8llg\u00e5rd","year":"1986","unstructured":"M\u00f8llg\u00e5rd, K. & Saunders, N. R. The development of the human blood-brain and blood-CSF barriers. Neuropathol. Appl. Neurobiol. 12, 337\u2013358 (1986).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2294_CR83","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00418-004-0665-1","volume":"122","author":"D Virgintino","year":"2004","unstructured":"Virgintino, D. et al. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem. Cell Biol. 122, 51\u201359 (2004).","journal-title":"Histochem. Cell Biol."},{"key":"2294_CR84","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1002\/jps.22487","volume":"100","author":"K Ito","year":"2011","unstructured":"Ito, K. et al. Quantitative membrane protein expression at the blood\u2013brain barrier of adult and younger cynomolgus monkeys. J. Pharm. Sci. 100, 3939\u20133950 (2011).","journal-title":"J. Pharm. Sci."},{"key":"2294_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay, S. et al. An essential receptor for adeno-associated virus infection. Nature 530, 108\u2013112 (2016).","journal-title":"Nature"},{"key":"2294_CR86","doi-asserted-by":"publisher","first-page":"e02213-17","DOI":"10.1128\/JVI.02213-17","volume":"92","author":"AM Dudek","year":"2018","unstructured":"Dudek, A. M. et al. An alternate route for adeno-associated virus entry independent of AAVR. J. Virol. 92, e02213-17 (2018).","journal-title":"J. Virol."},{"key":"2294_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116419","volume":"44","author":"C Lin","year":"2025","unstructured":"Lin, C. et al. AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain. Cell Rep. 44, 116419 (2025).","journal-title":"Cell Rep."},{"key":"2294_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi2245","volume":"16","author":"SJ Barker","year":"2024","unstructured":"Barker, S. J. et al. Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier. Sci. Transl. Med. 16, eadi2245 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2294_CR89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","volume":"605","author":"L Cao","year":"2022","unstructured":"Cao, L. et al. Design of protein-binding proteins from the target structure alone. Nature 605, 551\u2013560 (2022).","journal-title":"Nature"},{"key":"2294_CR90","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","volume":"620","author":"JL Watson","year":"2023","unstructured":"Watson, J. L. et al. De novo design of protein structure and function with RFdiffusion. Nature 620, 1089\u20131100 (2023).","journal-title":"Nature"},{"key":"2294_CR91","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.ymthe.2024.04.003","volume":"32","author":"X Ding","year":"2024","unstructured":"Ding, X., Chen, X., Sullivan, E. E., Shay, T. F. & Gradinaru, V. Fast, accurate ranking of engineered proteins by target-binding propensity using structure modeling. Mol. Ther. 32, 1687\u20131700 (2024).","journal-title":"Mol. Ther."},{"key":"2294_CR92","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20131660","volume":"211","author":"N Bien-Ly","year":"2014","unstructured":"Bien-Ly, N. et al. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. J. Exp. Med. 211, 233\u2013244 (2014).","journal-title":"J. Exp. Med."},{"key":"2294_CR93","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001787R","volume":"35","author":"P Stocki","year":"2021","unstructured":"Stocki, P. et al. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1. FASEB J. 35, e21172 (2021).","journal-title":"FASEB J."},{"key":"2294_CR94","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/jnc.14482","volume":"146","author":"AS Haqqani","year":"2018","unstructured":"Haqqani, A. S. et al. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood\u2013brain barrier in vitro is dependent on its binding affinity. J. Neurochem. 146, 735\u2013752 (2018).","journal-title":"J. Neurochem."},{"key":"2294_CR95","doi-asserted-by":"publisher","first-page":"308","DOI":"10.7150\/thno.17155","volume":"7","author":"G Hultqvist","year":"2017","unstructured":"Hultqvist, G., Syv\u00e4nen, S., Fang, X. T., Lannfelt, L. & Sehlin, D. Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor. Theranostics 7, 308\u2013318 (2017).","journal-title":"Theranostics"},{"key":"2294_CR96","first-page":"176\u2212192","volume":"26","author":"P Agarwal","year":"2014","unstructured":"Agarwal, P. & Bertozzi, C. R. Site-specific antibody\u2013drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development. Bioconjug. Chem. 26, 176\u2212192 (2014).","journal-title":"Bioconjug. Chem."},{"key":"2294_CR97","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1523\/JNEUROSCI.0237-23.2023","volume":"43","author":"A Bryant","year":"2023","unstructured":"Bryant, A. et al. Endothelial cells are heterogeneous in different brain regions and are dramatically altered in Alzheimer\u2019s disease. J. Neurosci. 43, 4541\u20134557 (2023).","journal-title":"J. Neurosci."},{"key":"2294_CR98","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","volume":"26","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Single-nucleus multi-region transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease. Nat. Neurosci. 26, 970\u2013982 (2023).","journal-title":"Nat. Neurosci."},{"key":"2294_CR99","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2017.05.011","volume":"57","author":"D Osgood","year":"2017","unstructured":"Osgood, D., Miller, M. C., Messier, A. A., Gonzalez, L. & Silverberg, G. D. Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier. Neurobiol. Aging 57, 178\u2013185 (2017).","journal-title":"Neurobiol. Aging"},{"key":"2294_CR100","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1021\/jo00408a041","volume":"43","author":"WC Still","year":"1978","unstructured":"Still, W. C., Kahn, M. & Mitra, A. Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 43, 2923\u20132925 (1978).","journal-title":"J. Org. Chem."},{"key":"2294_CR101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/laban0511-155","volume":"40","author":"T Yardeni","year":"2011","unstructured":"Yardeni, T., Eckhaus, M., Morris, H. D., Huizing, M. & Hoogstraten-Miller, S. Retro-orbital injections in mice. Lab Anim. (NY) 40, 155\u2013160 (2011).","journal-title":"Lab Anim. (NY)"},{"key":"2294_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38582-7","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates. Nat. Commun. 14, 3345 (2023).","journal-title":"Nat. Commun."},{"key":"2294_CR103","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1073\/pnas.93.24.13589","volume":"93","author":"T Stams","year":"1996","unstructured":"Stams, T. et al. Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-\u00c5 resolution. Proc. Natl Acad. Sci. USA 93, 13589\u201313594 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2294_CR104","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi, M. et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439\u2013D444 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2294_CR105","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02294-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:02:57Z","timestamp":1793991777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":105,"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1038\/s41589-026-02294-y","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.G., X.D., S.E.R., A.C.C., P.B., X.C., E.E.S. and S.J. are inventors on patent applications filed by the California Institute of Technology related to this work; the associated technology has been licensed to Receptive Bio, Inc. V.G. is a co-founder, scientific advisor and board observer of Receptive Bio; X.D. and X.C. are co-founders and employees; T.F.S. is a co-founder and scientific advisor; and E.E.S. and C.M.A. are employees. Receptive Bio did not provide funding and had no role in study design, data collection and analysis, the decision to publish or preparation of the manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}